Linked Life Data

12816913

Source:http://linkedlifedata.com/resource/pubmed/id/12816913

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2003-6-20
pubmed:abstractText
The nucleoside reverse transcriptase inhibitors used for the treatment of HIV-positive persons are now clearly associated with metabolic disorders. We determined the prevalence of and risk factors for hyperlactatemia in HIV-positive persons to assess the relevance of lactate venous blood concentrations during antiretroviral therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0009-9147
pubmed:author
pubmed:issnType
Print
pubmed:volume
49
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1154-62
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients.
pubmed:affiliation
Department of Biochemistry, Faculty of Medicine, University Hospital of Clermont-Ferrand, 28 Place Henri Dunant, BP. 38, 63000 Clermont-Ferrand, France.
pubmed:publicationType
Journal Article, Comparative Study